Rocket Pharmaceuticals
RCKT
RCKT
164 hedge funds and large institutions have $1.1B invested in Rocket Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 64 increasing their positions, 40 reducing their positions, and 14 closing their positions.
Holders
164
Holders Change
+17
Holders Change %
+11.56%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
31
Increased
64
Reduced
40
Closed
14
Calls
$10.2M
Puts
$902K
Net Calls
+$9.34M
Net Calls Change
+$8.82M
Top Buyers
| 1 |
DM
1
Deerfield Management
New York
|
$13.9M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$54.1M |
| 3 |
3
Goldman Sachs
New York
|
$32.5M |
| 4 |
4
BlackRock
New York
|
$71.7M |
| 5 |
ABG
5
Ally Bridge Group
New York
|
$7.65M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
Fifth Third Bancorp
Cincinnati,
Ohio
| – | – | -103 | Closed |
|
|
CFGS
177
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
NFSG
178
Newbridge Financial Services Group
Boca Raton,
Florida
| $0 | 18 | – | – |
|
|
CM
179
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
|
C
180
Covestor
London,
United Kingdom
| $0 | 7 | +7 | New |
|